Proteotech, Inc.
Records under this name other than the patents Proteotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,809,263 | Antigenic Composition for Detecting Auto-Antibody with Specific Response to Exosomal Protein EIF3A, and Method for Diagnosing Liver Cancer Using Antigenic Composition Formerly held In force · High confidence | In force | High confidence | |
| US 10,041,952 | Composition for Detecting Proteins Containing Tyrosine Oxide-Coupled Biomaterial Lapsed on the fee record Ended Aug 7, 2026 · High confidence | Lapsed on the fee record | Ended Aug 7, 2026 | High confidence |
| US 6,929,808 | Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants Formerly held Term ended Term ended Nov 2, 2021 · From the USPTO record | Term ended | Term ended Nov 2, 2021 | From the USPTO record |
| US 8,563,590 | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (IAPP) accumulation in diabetes Formerly held Lapsed on the fee record Ended Oct 22, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2021 | From the USPTO record |
| US 7,601,876 | Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis Formerly held Lapsed on the fee record Ended Oct 13, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 13, 2021 | From the USPTO record |
| US 8,455,687 | Compounds and compositions for use as modulators of tau aggregation and alleviation of tauopathies Formerly held Lapsed on the fee record Ended Jun 4, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 4, 2021 | From the USPTO record |
| US 7,514,583 | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease Formerly held Lapsed on the fee record Ended Apr 7, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 7, 2021 | From the USPTO record |
| US 9,469,605 | Compounds and compositions for use a modulators of tau aggregation and alleviation of tauopathies Formerly held Lapsed on the fee record Ended Oct 18, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 18, 2020 | From the USPTO record |
| US 9,334,251 | Compounds for the treatment of neurodegenerative diseases Formerly held Lapsed on the fee record Ended May 10, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2020 | From the USPTO record |
| US 8,163,957 | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease Formerly held Lapsed on the fee record Ended Apr 24, 2020 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2020 | From the USPTO record |